These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7496088)

  • 1. Successful hematopoietic reconstitution with granulocyte colony-stimulating factor in a patient with hypoplastic acute myelogenous leukemia.
    Lee M; Chubachi A; Niitsu H; Miura I; Yanagisawa M; Hirokawa M; Miura AB
    Intern Med; 1995 Jul; 34(7):692-4. PubMed ID: 7496088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remission induction by granulocyte colony-stimulating factor in hypoplastic acute myelogenous leukemia complicated by infection. A case report and review of the literature.
    Takamatsu Y; Miyamoto T; Iwasaki H; Makino S; Tamura K
    Acta Haematol; 1998; 99(4):224-30. PubMed ID: 9644302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete remission in a patient with hypoplastic acute lymphoblastic leukemia induced by granulocyte-colony-stimulating factor.
    Hatta Y; Iwata T; Takeuchi J; Ohshima T; Horie T
    Acta Haematol; 1995; 94(1):39-43. PubMed ID: 7544523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical effect of granulocyte colony-stimulating factor on neutrophils and leukemic cells in myelogenous leukemia: analysis.
    Ishikawa J; Yoshimura M; Matsunashi T; Tominaga N; Teshima H; Hiraoka A; Nakamura H; Shibata H; Masaoka T; Takaku F
    Jpn J Clin Oncol; 1991 Jun; 21(3):169-75. PubMed ID: 1719259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of granulocyte colony-stimulating factor before, during, and after fludarabine plus cytarabine induction therapy of newly diagnosed acute myelogenous leukemia or myelodysplastic syndromes: comparison with fludarabine plus cytarabine without granulocyte colony-stimulating factor.
    Estey E; Thall P; Andreeff M; Beran M; Kantarjian H; O'Brien S; Escudier S; Robertson LE; Koller C; Kornblau S
    J Clin Oncol; 1994 Apr; 12(4):671-8. PubMed ID: 7512125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose total body irradiation and G-CSF without hematopoietic stem cell support in the treatment of relapsed or refractory acute myelogenous leukemia (AML), or AML in second or subsequent remission.
    Shulman LN; Tarbell NJ; Storen E; Marcus K; Mauch PM
    Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):1113-7. PubMed ID: 9869237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of the cellular metabolism of cytarabine and fludarabine by granulocyte-colony-stimulating factor during therapy of acute myelogenous leukemia.
    Gandhi V; Estey E; Du M; Nowak B; Keating MJ; Plunkett W
    Clin Cancer Res; 1995 Feb; 1(2):169-78. PubMed ID: 9815970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematological remission and long term hematological control of acute myeloblastic leukemia induced and maintained by granulocyte-colony stimulating factor (G-CSF) therapy.
    Xavier L; Cunha M; Gonçalves C; Teixeira Mdos A; Coutinho J; Ribeiro AC; Lima M
    Leuk Lymphoma; 2003 Dec; 44(12):2137-42. PubMed ID: 14959860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High remission rate, short remission duration in patients with refractory anemia with excess blasts (RAEB) in transformation (RAEB-t) given acute myelogenous leukemia (AML)-type chemotherapy in combination with granulocyte-CSF (G-CSF).
    Estey EH; Kantarjian HM; O'Brien S; Kornblau S; Andreeff M; Beran M; Pierce S; Keating M
    Cytokines Mol Ther; 1995 Mar; 1(1):21-8. PubMed ID: 9384660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fludarabine, cytarabine, granulocyte colony-stimulating factor and idarubicin for relapsed childhood acute myeloid leukemia.
    Nakayama H; Tomizawa D; Tanaka S; Iwamoto S; Shimada A; Saito AM; Yamashita Y; Moritake H; Terui K; Taga T; Matsuo H; Kosaka Y; Koh K; Hosoi H; Kurosawa H; Isoyama K; Horibe K; Mizutani S; Adachi S
    Pediatr Int; 2017 Oct; 59(10):1046-1052. PubMed ID: 28771903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic analysis of granulocyte colony stimulating factor as adjunct therapy for older patients with acute myelogenous leukemia (AML): estimates from a Southwest Oncology Group clinical trial.
    Bennett CL; Hynes D; Godwin J; Stinson TJ; Golub RM; Appelbaum FR;
    Cancer Invest; 2001; 19(6):603-10. PubMed ID: 11486703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact on acute myeloid leukemia relapse in granulocyte colony-stimulating factor application: a meta-analysis.
    Feng X; Lan H; Ruan Y; Li C
    Hematology; 2018 Oct; 23(9):581-589. PubMed ID: 29516766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete remission in hypoplastic acute myeloid leukemia induced by G-CSF without chemotherapy: report on three cases.
    Nimubona S; Grulois I; Bernard M; Drénou B; Godard M; Fauchet R; Lamy T
    Leukemia; 2002 Sep; 16(9):1871-3. PubMed ID: 12200710
    [No Abstract]   [Full Text] [Related]  

  • 14. Successful treatment of childhood hypocellular acute myeloid leukemia.
    Yamamoto M; Hori T; Hatakeyama N; Igarashi K; Iesato K; Nakanishi K; Noguchi H; Miyachi H; Ito M; Tsutsumi H; Suzuki N
    J Pediatr Hematol Oncol; 2012 Jul; 34(5):398-401. PubMed ID: 22278198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose dependent long-term in vivo remission of AML1/ETO positive acute myeloid leukemia with G-CSF.
    Zomas A; Stefanoudaki-Sofianatou K; Fisfis M; Anagnostopoulos NI
    Hematology; 2004 Apr; 9(2):107-11. PubMed ID: 15203865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy with granulocyte colony-stimulating factor, all-trans retinoic acid, and low-dose cytotoxic drugs for acute myelogenous leukemia.
    Usuki K; Kitazume K; Endo M; Ito K; Iki S; Urabe A
    Intern Med; 1995 Dec; 34(12):1186-9. PubMed ID: 8929647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between the proliferative response to granulocyte colony-stimulating factor and the positivity of transferrin receptor in acute myeloblastic leukemia cells.
    Motoji T; Mineshima M; Watanabe M; Takanashi M; Masuda M; Oshimi K; Mizoguchi H
    J Cell Physiol; 1991 Sep; 148(3):421-5. PubMed ID: 1717498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of interleukin-6 and granulocyte colony-stimulating factor on the proliferation of leukemic blast progenitors from acute myeloblastic leukemia patients.
    Suzuki T; Morio T; Tohda S; Nagata K; Yamashita Y; Imai Y; Aoki N; Hirashima K; Nara N
    Jpn J Cancer Res; 1990 Oct; 81(10):979-86. PubMed ID: 1699919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Transformation of aplastic anemia to acute myeloid leukemia with myelofibrosis following treatment with granulocyte colony-stimulating factor and erythropoietin].
    Tsurumi H; Yamada T; Hara T; Murakami N; Moriwaki H; Muto Y
    Rinsho Ketsueki; 1996 Jul; 37(7):630-2. PubMed ID: 8779784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I study of cladribine, cytarabine (Ara-C), granulocyte colony stimulating factor (G-CSF) (CLAG Regimen) and simultaneous escalating doses of imatinib mesylate (Gleevec) in relapsed/refractory AML.
    Walker AR; Komrokji RS; Ifthikharuddin J; Messina P; Mulford D; Becker M; Friedberg J; Oliva J; Phillips G; Liesveld JL; Abboud C
    Leuk Res; 2008 Dec; 32(12):1830-6. PubMed ID: 18571721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.